Dr.  

Jeffrey Crowley


Presentations

Efficacy and Safety of Long-Term Tildrakizumab for Plaque Psoriasis: 4-Year Results from reSURFACE 1 09 October 2019 00:00 - 00:00

Abstracts

Efficacy and Safety of Long-Term Tildrakizumab for Plaque Psoriasis: 4-Year Results from reSURFACE 1 Psoriasis More